Clinical management following self-harm in a UK-wide primary care cohort

Article English OPEN
Carr, Matthew J. ; Ashcroft, Darren M. ; Kontopantelis, Evangelos ; While, David ; Awenat, Yvonne ; Cooper, Jayne ; Chew-Graham, Carolyn ; Kapur, Nav ; Webb, Roger T. (2016)
  • Publisher: Elsevier BV
  • Journal: Journal of Affective Disorders, volume 197, pages 182-188 (issn: 0165-0327, eissn: 1573-2517)
  • Related identifiers: pmc: PMC4870375, doi: 10.1016/j.jad.2016.03.013
  • Subject: Clinical Psychology | NICE, National Institute for Health and Clinical Excellence | Medication | UK, United Kingdom | CI, Confidence Interval | SSRI, Selective Serotonin Reuptake Inhibitor | Diagnoses | GP, General Practitioner | Psychiatry and Mental health | NHS, National Health Service | Referrals | CPRD, Clinical Practice Research Datalink | LSOA, Lower-Layer Super Output Area | YLL, Years of Life Lost | Primary care | FHSA, Family Health Services Authority | Self-harm | Research Paper | MHRA, Medicines and Healthcare products Regulatory Agency | IMD, Index of Multiple Deprivation | R1

Background\ud Little is known about the clinical management of patients in primary care following self-harm.\ud \ud Methods\ud A descriptive cohort study using data from 684 UK general practices that contributed to the Clinical Practice Research Datalink (CPRD) during 2001–2013. We identified 49,970 patients with a self-harm episode, 41,500 of whom had one complete year of follow-up.\ud \ud Results\ud Among those with complete follow-up, 26,065 (62.8%, 62.3–63.3) were prescribed psychotropic medication and 6318 (15.2%, 14.9-15.6) were referred to mental health services; 4105 (9.9%, CI 9.6–10.2) were medicated without an antecedent psychiatric diagnosis or referral, and 4,506 (10.9%, CI 10.6–11.2) had a diagnosis but were not subsequently medicated or referred. Patients registered at practices in the most deprived localities were 27.1% (CI 21.5–32.2) less likely to be referred than those in the least deprived. Despite a specifically flagged NICE 'Do not do’ recommendation in 2011 against prescribing tricyclic antidepressants following self-harm because of their potentially lethal toxicity in overdose, 8.8% (CI 7.8-9.8) of individuals were issued a prescription in the subsequent year. The percentage prescribed Citalopram, an SSRI antidepressant with higher toxicity in overdose, fell sharply during 2012/2013 in the aftermath of a Medicines and Healthcare products Regulatory Agency (MHRA) safety alert issued in 2011.\ud \ud Conclusions\ud A relatively small percentage of these vulnerable patients are referred to mental health services, and reduced likelihood of referral in more deprived localities reflects a marked health inequality. National clinical guidelines have not yet been effective in reducing rates of tricyclic antidepressant prescribing for this high-risk group.
  • References (28)
    28 references, page 1 of 3

    Bergen, H., Hawton, K., Webb, R., Cooper, J., Steeg, S., Haigh, M., Ness, J., Waters, K., Kapur, N., 2014. Alcohol-related mortality following self-harm: a multicentre cohort study. J. R. Soc. Med. Open. 5, 1-11.

    Bergen, H., Murphy, E., Cooper, J., Kapur, N., Stalker, C., Waters, K., Hawton, K. 2010. A comparative study of non-fatal self-poisoning with antidepressants relative to prescribing in three centres in England. J. Affect. Disord. 123, 95-101.

    Carr, M.J., Ashcroft, D.M., Kontopantelis, E., Awenat, Y., Cooper, J., Chew-Graham, C., Kapur, N., Webb, R.T., 2015. The epidemiology of self-harm in the UK primary care patient population, 2001-2013. [Accepted for publication in BMC Psychiatry].

    Chew-Graham, C.A., Mullin, S., May, C.R., Hedley, S., Cole, H. 2002. Managing depression in primary care: another example of the inverse care law? Fam. Pract. 19, 632-7.

    Chisholm, J. 1990. The Read clinical classification. BMJ 300(6732), 1092.

    Cooper, J., Kapur, N., Webb, R., Lawlor, M., Guthrie, E., Mackway-Jones, K., Appleby, L., 2007. Suicide after deliberate self-harm: a 4-year cohort study. Am. J. Psychiatry 162, 297-303.

    De Leo, D., Padoani, W., Scocco, P., Lie, D., Bille-Brahe, U., Arensman, E., Hjelmeland, H., Crepet, P., Haring, C., Hawton, K., Lonnqvist, J., Michel, K., Pommereau, X., Querejeta, I., Phillipe, J., Salander-Renberg, E., Schmidtke, A., Fricke, S., Weinacker, B., Tamesvary, B., Wasserman, D., Faria, S., 2001. Attempted and completed suicide in older subjects: results from the WHO/EURO Multicentre Study of Suicidal Behaviour. In. J. Geriatr. Psychiatry 16, 300-10.

    Finkelstein, Y., Macdonald, E.M., Hollands, S., Hutson, J.R., Sivilotti, M.L.A., Mamdani, M.M., Koren, G., Juurlink, D.N., 2015a. Long-term outcomes following self-poisoning in adolescents: a population-based cohort study. Lancet Psychiatry 2, 532-9.

    Finkelstein, Y., Macdonald, E.M., Hollands, S., Sivilotti, M.L.A., Hutson, J.R., Mamdani, M.M., Koren, G., Juurlink, D.N., 2015b. Risk of suicide following deliberate selfpoisoning. JAMA Psychiatry 72, 570-5.

    FirstDataBank. 2014. MULTILEX. http://www.fdbhealth.co.uk/solutions/multilex/

  • Related Research Results (1)
  • Metrics
    No metrics available
Share - Bookmark